IL6 and Fabry disease: Of note, as the homeostatic and protective action of IL-6 is mediated by the activation of the membrane receptor IL-6R in target cells, the slightly lower levels of it in FD patients further corroborate a scenario where IL-6 pathogenic signals prevail over its homeostatic action.